Skip to content

The Influence of Compression Stockings on Skin's Barrier Function at Patients With Chronic Venous Disease

Prospective, Randomized and Explorative Controlled Study About Influences of Compression Stockings on Skin's Barrier Function at Patients With Chronic Venous Insufficiency

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00196443
Enrollment
42
Registered
2005-09-20
Start date
2005-06-30
Completion date
2005-07-31
Last updated
2005-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Venous Insufficiency

Brief summary

The purpose of this study is to investigate if wearing of compression stockings influences the skin moisture. Conservative stockings are compared with urea containing compression stockings to find out if using urea prevents dehydration of the skin while wearing the urea compression stockings. Secondary aim was to find out if urea containing stockings increase the compliance to wear the compression stockings regulary by patients with diagnosed chronic venous insufficiency.

Interventions

DEVICEurea contained compressing stockings
DEVICEcompressing stockings

Sponsors

Bauerfeind AG, Zeulenroda, Germany
CollaboratorUNKNOWN
University Medicine Greifswald
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Clincial diagnosis of chronic venous insufficiency * Age: 18-80 years * Patient's information and willingness to participate

Exclusion criteria

* Age under 18 years * Lower limp edema not caused by venous insufficiency * Acute deep venous thrombosis * Arterial occlusive disease * Diabetes mellitus with neuropathy or peripheral arterial disturbance of perfusion * immobile Patients * Pregnancy

Design outcomes

Primary

MeasureTime frame
skin moisture at day 0 and day 7
loss of water throughout epidermis at day 0 and day 7
throatiness of epidermis at day 0 and day 7

Secondary

MeasureTime frame
compliance of patients at every day of intervention

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026